Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,210.16 -5.67 (-0.47%)
Streaming Delayed Price Updated: 11:46 AM EDT, Jul 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Dr. Danielle Carrera’s Beyond Better, Thrive Debuts as Amazon #1 New Release and Top 5 Bestseller
Via Get News
News headline image
Here's Why Viking Therapeutics Stock Surged Higher in June ↗
Investors are growing more optimistic over the company's pipeline and the initiation of a Phase 1 trial with a new drug. 
Via The Motley Fool
News headline image
SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns ↗
Compare portfolio diversity, risk profiles, and income potential as you weigh these two leading healthcare ETFs. 
Via The Motley Fool
Topics ETFs
News headline image
Innovent, Eli Lilly Partner to Commercialize Breast Cancer Drug in China ↗
Innovent and Eli Lilly sign a China commercialization deal for Verzenios, expanding patient access while Lilly retains manufacturing. 
Via Benzinga
News headline image
$100 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today ↗
Eli Lilly (NYSE:LLY) has outperformed the market over the past 20 years by 7.2% on an annualized basis producing an average annual return of 16.46%. Currently, Eli Lilly has a market capitalization of... 
Via Benzinga
News headline image
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
From Biotech Insider
Via GlobeNewswire
News headline image
Q1 Rundown: Phibro Animal Health (NASDAQ:PAHC) Vs Other Branded Pharmaceuticals Stocks
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Phibro Animal Hea... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Branded Pharmaceuticals Stocks Q1 Teardown: Zoetis (NYSE:ZTS) Vs The Rest
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Zoetis (NYSE:ZTS) and its pee... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Why Illumina (ILMN) Stock Is Down Today
What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 1.9% in the afternoon session after Swiss drugmaker Roche launched a next-generation ge... 
Via StockStory
News headline image
Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness ↗
FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after receiving more than 80 applications. 
Via Benzinga
News headline image
3 Magnificent Dividend ETFs That Could Supercharge Your Passive Income ↗
All three ETFs complement each other well in a portfolio. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
Ranking Wall Street's Trillion-Dollar Stocks From Most to Least Attractive, Based on Future Cash Flow ↗
Among Nvidia, Apple, Alphabet, Microsoft, Amazon, Taiwan Semi, SpaceX, Broadcom, Tesla, Meta, Micron, Eli Lilly, and Berkshire Hathaway, there are a handful of bargains and pretenders. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
5 Reasons Eli Lilly Is a Better Stock to Buy Right Now Than SpaceX ↗
SpaceX recently completed a record IPO. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
News headline image
Eli Lilly Is Dominating the GLP-1 Market: Here's What a $5,000 Investment Could Look Like in 5 Years ↗
The weight loss tailwind isn't about to come to a halt. 
Via The Motley Fool
News headline image
Big Pharma Has a Case of Merger Mania ↗
Pharmaceutical companies are on an M&A spree that could break records this year as they look for novel drug and clinical-stage candidates to bolster the development pipeline. 
Via The Motley Fool
Topics Intellectual Property
News headline image
5 Places Investors Can Hide If the AI Trade Keeps Cracking ↗
As AI stocks face volatility, capital is rotating into biotech, industrials, utilities, consumer staples, and dividend ETFs showing relative strength. 
Via MarketBeat
Topics Artificial Intelligence ETFs
News headline image
3 Monster Stocks to Buy Right Now With Dividend Yields of 5% or More ↗
Why settle for puny yields when you can buy these monster dividend stocks? 
Via The Motley Fool
Topics ETFs Energy
News headline image
2 Top Growth Stocks to Buy Right Now Without Hesitation ↗
These stocks are no-brainer buys. 
Via The Motley Fool
Topics Economy
News headline image
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗
These stocks are better bets to skyrocket than the much-hyped rocket stock. 
Via The Motley Fool
News headline image
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now ↗
Pfizer is deeply out of favor on Wall Street, which could be a huge opportunity for long-term dividend investors. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates ↗
The top stocks are showing relative strength. Two are defensive growth plays. 
Via Investor's Business Daily
News headline image
Revealed! 3 Undervalued Stocks I Just Bought ↗
There are still great opportunities in an otherwise volatile market. 
Via The Motley Fool
News headline image
Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy? ↗
Eli Lilly holds a dominant market share in the weight loss treatment category. 
Via The Motley Fool
News headline image
Why Eli Lilly Stock Jumped to a New All-Time High Today ↗
The pharma titan is expanding into new markets. 
Via The Motley Fool
News headline image
Lilly Hits Record High Amid Massive Profit Growth, Leads 28 Just Added To Best Stock Lists ↗
Eli Lilly is a leader in the revolutionary GLP weight-loss market. Lilly was one of 28 stocks new to best stock lists Friday. 
Via Investor's Business Daily
News headline image
Better Buy in the Obesity Drug Race: Novo Nordisk or Eli Lilly? ↗
Novo Nordisk offers dividend income and MASH upside versus Lilly's high‑growth obesity lead. 
Via The Motley Fool
Discover which S&P500 stocks are making waves on Friday. ↗
Via Chartmill
News headline image
Why Is Eli Lilly (LLY) Stock Soaring Today
What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 6.3% in the afternoon session after the European Medicines Agency's commit... 
Via StockStory
News headline image
Snap’s Specs Gamble ↗
The smartphone could be a thing of the past if Snap has its way. But at $2,195, it could be a tall order to sell Specs to consumers, even if they were stylish. 
Via The Motley Fool
Topics Workforce
Friday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.